Institution profile

医療法人社団 東京Dタワーホスピタル

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01C2510082 +3

Location

Prefecture
Tokyo
Address
東京都江東区豊洲6丁目4番20号Dタワー豊洲 1階・3階~5階

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIINot registered

Certified committee for regenerative medicine

  • 安全未来特定認定再生医療等委員会
  • 特定非営利活動法人 先端医療推進機構 特定認定再生医療等委員会 名古屋

Public score

57.4/ 100

A · Review level
25.0 / 30
B · Technologies
18.5 / 35
C · Coverage
7.1 / 25
D · Class I / II technologies
6.7 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 233of 1736

Registered technologies
4
Areas covered
2

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 57.4
Public score →100

Registered technologies (4)

Stem cells (all sources) 4
Registered technologies · Japanese originalTechnology areasPlan classification
慢性疼痛に対する脂肪組織由来幹細胞移植治療Stem cells (all sources)Adipose-derived stem cellsClass II
脂肪組織由来再生(幹)細胞を用いた慢性疼痛に対する治療Stem cells (all sources)Adipose-derived stem cellsClass II
脂肪組織由来再生(幹)細胞を用いた変形性関節症に対する治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
変形性関節症に対する脂肪組織由来幹細胞移植治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
Adipose-derived stem cells 4
Registered technologies · Japanese originalTechnology areasPlan classification
慢性疼痛に対する脂肪組織由来幹細胞移植治療Stem cells (all sources)Adipose-derived stem cellsClass II
脂肪組織由来再生(幹)細胞を用いた慢性疼痛に対する治療Stem cells (all sources)Adipose-derived stem cellsClass II
脂肪組織由来再生(幹)細胞を用いた変形性関節症に対する治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
変形性関節症に対する脂肪組織由来幹細胞移植治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
Joints and musculoskeletal 2
Registered technologies · Japanese originalTechnology areasPlan classification
脂肪組織由来再生(幹)細胞を用いた変形性関節症に対する治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
変形性関節症に対する脂肪組織由来幹細胞移植治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II

Certified committee for regenerative medicine

  • 安全未来特定認定再生医療等委員会
  • 特定非営利活動法人 先端医療推進機構 特定認定再生医療等委員会 名古屋

Public document number

  • 01C2510082
  • 01C2511011
  • 01C2510079
  • 01C2510081
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
慢性疼痛に対する脂肪組織由来幹細胞移植治療Class II安全未来特定認定再生医療等委員会01C2510082
変形性関節症に対する脂肪組織由来幹細胞移植治療Class II特定非営利活動法人 先端医療推進機構 特定認定再生医療等委員会 名古屋01C2511011
脂肪組織由来再生(幹)細胞を用いた慢性疼痛に対する治療Class II安全未来特定認定再生医療等委員会01C2510079
脂肪組織由来再生(幹)細胞を用いた変形性関節症に対する治療Class II安全未来特定認定再生医療等委員会01C2510081

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor